Trademark Search
Owners
ImmunoGen, Inc.
ELAHERE MIRVETUXIMAB SORAVTANSINE INJECTION 100 MG SUPPORT SERVICES
to examiner
on 01 Apr 2024
Last Applicant/ Owned by
830 Winter Street
Waltham
MA
02451
Serial Number
97693879 filed on 28th Nov 2022
Registration Number
N/A
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
"SUPPORT SERVICES" AND "MIRVETUXIMAB SORAVTANSINE INJECTION 100 MG"
"SUPPORT SERVICES" AND "MIRVETUXIMAB SORAVTANSINE INJECTION 100 MG" Informational counseling for patients, namely, providing information and assistance with respect to obtaining prescription medications for medical purposes Business administration of patient pharmaceutical reimbursement programs; business administration of a patient support program for facilitating access to, distribution of, anRead More
Informational counseling for patients, namely, providing information and assistance with respect to obtaining prescription medications for medical purposes
31st Dec 2023
31st Dec 2023
Providing health insurance information about health insurance benefits, medication insurance coverage, insurance reimbursement, insurance payer policies and patient financial assistance to patients; financial consultation to medical patients in identification of health insurance alternatives; providing patient assistance programs, namely, providing financial assistance programs to provide access to pharmaceutical preparations at low or no cost to qualified uninsured and underinsured patients who have a demonstrated financial need
31st Dec 2023
31st Dec 2023
Business administration of patient pharmaceutical reimbursement programs; business administration of a patient support program for facilitating access to, distribution of, and reimbursement for pharmaceutical products
31st Dec 2023
31st Dec 2023
No 97693879
No Service Mark
No 32827-50494
No
No
No
No
No
No
No
No
01.15.25 -
Other natural phenomena and observable events
26.11.11 -
Rectangles divided twice into three sections
26.11.14 -
Three or more rectangles
26.11.21 -
Rectangles that are completely or partially shaded
The mark consists of the word "ELAHERE" in block capital letters, stacked above "mirvetuximab soravtansine", "injection 100 mg", and "SUPPORT SERVICES", with the design of a half circle sunburst to the left of these words made up of trapezoid-shaped lines, each divided into three sections of different shades, arrayed around the upper left corner of the first "E" in "ELAHERE".
| Status Date | Action Taken |
|---|---|
| 01st Apr 2024 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 01st Apr 2024 | STATEMENT OF USE PROCESSING COMPLETE |
| 09th Mar 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 08th Mar 2024 | SOU TEAS EXTENSION RECEIVED |
| 08th Mar 2024 | SOU EXTENSION 1 FILED |
| 08th Mar 2024 | SOU EXTENSION 1 GRANTED |
| 08th Mar 2024 | TEAS STATEMENT OF USE RECEIVED |
| 08th Mar 2024 | USE AMENDMENT FILED |
| 03rd Oct 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 08th Aug 2023 | PUBLISHED FOR OPPOSITION |
